RNAi-mediated inhibition of gremlin for treatment of IOP-related conditions

Details for Australian Patent Application No. 2007286545 (hide)

Owner Alcon Research, Ltd

Inventors Chatterton, Jon E.; Clark, Abbot F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007286545

PCT Pub. Number WO2008/024983

Priority 60/839,826 24.08.06 US

Filing date 24 August 2007

Wipo publication date 28 February 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/024983 Priority application(s): WO2008/024983

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286582-Methods for improving the HF capture efficiency of dry scrubbers

2007286532-Touch screen device, method, and graphical user interface for determining commands by applying heuristics